Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Vectus Biosystems Limited has requested a trading halt for its securities pending an announcement regarding a material transaction related to its drug library. The halt is set to last for up to two days, with trading expected to resume unless the ASX decides otherwise. The company anticipates making the announcement before trading resumes on the specified date.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-1156
Vectus Biosystems Limited on 6ix
Earlier from Vectus Biosystems
- Pause in Trading
- Preliminary Final Report
- Agreement with C14 Consulting Group
- Passing of Vectus CEO
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Vectus Biosystems
- Suspension from Quotation
- VB4-P5 Renal Compound Transaction
- Reinstatement to Quotation
- Response to ASX Query Letter
- Quarterly Activities & Appendix 4C Cash Flow Reports
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems